𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical and immunologic responses to levamisole in 13 patients with erythema multiforme

✍ Scribed by Francina Lozada; Lynn Spitler; S. Silverman Jr.


Publisher
Elsevier Science
Year
1980
Tongue
English
Weight
438 KB
Volume
2
Category
Article
ISSN
0192-0561

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Variability of the immunologic and clini
✍ Charulata Sankhla; Dr. Joseph Jankovic; Drake Duane πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 463 KB

Immunoresistance (Ab+) to botulinum toxin type A (BTX-A) has been a serious concern since the introduction of BTX-A in the treatment of dystonia and other disorders associated with abnormal muscle contractions. We studied seven patients who developed Ab+ and later reverted to antibody-negative (Ab-)

Sleep electroencephalography and the cli
✍ Simon Carette; Gerald Oakson; Chantal Guimont; Mircea Steriade πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 666 KB

Objective. To determine the prevalence and clinical correlations of an anomaly consisting of electroencephalographic (EEG) waves within the alpha frequency band during non-rapid eye movement (NREM) sleep in patients with fibromyalgia, and to evaluate the alpha NREM sleep anomaly as a predictor of re

Intradermal ras peptide vaccination with
✍ Marianne K. Gjertsen; Trond Buanes; Arne R. Rosseland; Arne Bakka; Ivar Gladhaug πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 263 KB

K-RAS mutations are frequently found in adenocarcinomas of the pancreas, and induction of immunity against mutant ras can therefore be of possible clinical benefit in patients with pancreatic cancer. We present data from a clinical phase I/II trial involving patients with adenocarcinoma of the pancr

Development of antiinfliximab antibodies
✍ Gerrit Jan Wolbink; Marijn Vis; Willem Lems; Alexandre E. Voskuyl; Els De Groot; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 2 views

## Abstract ## Objective Treatment of patients with infliximab, a chimeric monoclonal IgG1 antibody against tumor necrosis factor, may result in the formation of infliximab‐specific IgG antibodies. This study evaluated the clinical significance of these antibodies in patients with rheumatoid arthr